BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1165 related articles for article (PubMed ID: 24727334)

  • 1. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
    Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
    Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation.
    Duque-Afonso J; Ihorst G; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Prasse A; Marks R
    Bone Marrow Transplant; 2013 Aug; 48(8):1098-103. PubMed ID: 23376822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
    Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature.
    Soubani AO; Kingah P; Alshabani K; Muma G; Haq A
    Clin Transplant; 2014 Jul; 28(7):776-82. PubMed ID: 24754643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
    Duque-Afonso J; Ihorst G; Waterhouse M; Zeiser R; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Marks R; Prasse A
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2277-2284. PubMed ID: 29964193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
    Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
    Slack JL; Dueck AC; Fauble VD; Sproat LO; Reeder CB; Noel P; Khera N; Betcher JA; Klein JL; Leis JF; Adams RH
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1167-74. PubMed ID: 23664940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
    Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):703-11. PubMed ID: 16785059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pulmonary complications after nonmyeloablative and conventional allogeneic hematopoietic cell transplant.
    Diab KJ; Yu Z; Wood KL; Shmalo JA; Sheski FD; Farber MO; Wilkes DS; Nelson RP
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1827-34. PubMed ID: 22766224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
    Dey BR; McAfee S; Sackstein R; Colby C; Saidman S; Weymouth D; Poliquin C; Vanderklish J; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2001; 7(11):604-12. PubMed ID: 11760148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation.
    Gassas A; Schechter T; Krueger J; Craig-Barnes H; Sung L; Ali M; Dell S; Egeler RM; Zaidman I; Palaniyar N
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1524-8. PubMed ID: 25963919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT.
    Holm AM; Riise GC; Hansson L; Brinch L; Bjørtuft O; Iversen M; Simonsen S; Fløisand Y
    Bone Marrow Transplant; 2013 May; 48(5):703-7. PubMed ID: 23064037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakasone H; Kanda J; Yano S; Atsuta Y; Ago H; Fukuda T; Kakihana K; Adachi T; Yujiri T; Taniguchi S; Taguchi J; Morishima Y; Nagamura T; Sakamaki H; Mori T; Murata M;
    Transpl Int; 2013 Jun; 26(6):631-9. PubMed ID: 23551210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-lung transplantation: does side matter?
    Tsagkaropoulos S; Belmans A; Verleden GM; Coosemans W; Decaluwe H; De Leyn P; Nafteux P; Van Raemdonck D
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):e83-92. PubMed ID: 21497108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of allogeneic haemopoietic stem cell transplants at a small New Zealand centre: does size matter?
    Ganly P; Cole S; Trengrove A; Butler A
    Intern Med J; 2014 Jul; 44(7):683-9. PubMed ID: 24750295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions.
    Hefazi M; Langer KJ; Khera N; Adamski J; Roy V; Winters JL; Gastineau DA; Jacob EK; Kreuter JD; Gandhi MJ; Hogan WJ; Litzow MR; Hashmi SK; Yadav H; Iyer VN; Scott JP; Wylam ME; Cartin-Ceba R; Patnaik MM
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1906-1913. PubMed ID: 29679771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.